We present a case of undifferentiated carcinoma of the esophagus (UCE) treated with chemotherapy consisting of 5-fluorouracil plus nedaplatin and radiotherapy. The patient developed rapid growth of lymph nodes and died of massive hematemesis 2 months after the diagnosis. UCE is rare but highly malignant. Since there is no established treatment for UCE, its clinical outcome is invariably poor. We also reviewed the effectiveness of chemotherapy against UCE.
InuiA.: Recent development in research and management of cancer anorexia-cachexia syndrome.Jpn J Cancer Chemother, 32: 743–749, 2005.
2.
TakemuraM., HigashinoM., OsugiH., TokuharaT., TakadaN., FujiwaraK., KatoH., IharaT., KinoshitaH.: Clinicopathological and immunohistochemical evaluation of undifferentiated carcinoma of the esophagus.Jpn J Gastroenterol Surg, 30: 694–699, 1997.
3.
MurakamiR., YamashitaY., OkudaT., TsuchigameT., TakahashiM., MiyamotoD., OgawaM., NishimuraH.: An undifferentiated carcinoma of the esophagus: A case report.Jpn J Cancer Clin, 37: 1192–1196, 1991.
4.
Japanese Society for Esophageal Diseases:Guidelines for clinical and pathologic studies of carcinoma of the esophagus (9th edition).Kanehara Syuppan, Tokyo, Japan, 1999.
5.
TakemuraM., HigashinoM., OsugiH., TokuharaT., TakadaN., FujiwaraK., KatoH., IharaT., KinoshitaH.: Clinicopathological and immunohistochemical evaluation of undifferentiated carcinoma of the esophagus.Jpn J Gastroenterol Surg, 30: 694–699, 1997.
6.
KankiK., YoshizumiY., MorisakiY., SugiuraY., TamaiS., AidaS., ShimaS., TanakaS.: Undifferentiated carcinoma with lymphoid stroma of the esophagus.Jpn J Gastroenterol Surg, 30: 754–758, 1997.
7.
MaruyamaM., KudoT., KuwabaraH., TakamatsuS., SuganoN., EbuchiM., TakizawaT.: High sensitivity for the chemotherapy in non-small cell esophageal carcinoma with high serum neuron-specific enolase.J Jpn Soc Cancer Ther, 32: 199–204, 1997.
8.
OnumaS., YoshidaM., HanashiT.: A case of undifferentiated carcinoma (non-small-cell type) of the esophagus successfully treated with preoperative chemotherapy.J Jpn Surg Assoc, 60: 697–702, 1999.
9.
NemotoH., TakeuchiS., NagasakiH., YoshizawaY., KikuchiH., YagiH., MidorikawaT., SanadaY., KumadaK., IwashigeM., TakizawaK., TateG.: Complete remission of esophageal undifferentiated carcinoma with nedaplatin and 5-FU chemotherapy and endoesophageal brachytherapy.Jpn J Cancer Chemother, 30: 263–267, 2003.
10.
SaitoS., HosoyaY., AraiW., HyodoM., YokoyamaT., HirashimaY., KurashinaK., NagaiH., TukaharaM., SaitoK.: Undifferentiated carcinoma of the esophagus (non-small cell type): A case report and review of the literature in Japan.Jpn J Gastroenterol Surg, 38: 19–24, 2005.
11.
HayataK., IwahashiM., NakamuraM., NakamoriM., NakataniY., IshidaK., NakaT., IidaT., MoriI., YamaueH.: Well differentiated squamous cell carcinoma of the esophagus showing dedifferentiation to undifferentiated carcinoma at metastatic lymph nodes.Jpn J Gastroenterol Surg, 39: 283–288, 2006.
12.
TaguchiT., WakuiA., NabeyaK., KuriharaM., IsonoK., KakegawaT., OtaK.: A phase II clinical study of cis-diammine glycolato platinum, 254–S, for gastrointestinal cancers.Jpn J Cancer Chemother, 19: 483–488, 1992.
13.
YoshiokaT., GamouM., ShinehaR., IshibashiS., ShibataH., SuzukiT., MurakawaY., KatoS., IshiokaC., KanamaruR.: A new combination chemotherapy with cisdiammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancer.Intern Med, 38: 844–848, 1999.
14.
YamanakaH., MotohiroT., MichiuraT., AsaiA., MoriT., HiokiK.: Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer.Jpn J Thorac Cardiovasc Surg, 46: 943–948, 1998.
FlamenP., LerutA., Van CutsemE., De WeverW., PeetersM., StroobantsS., DupontP., BormansG., HieleM., LeynP.D., RaemdonckD.V., CoosemansW., EctorsN., HaustermansK., MortelmansL.: Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.J Clin Oncol, 18: 3202–3210, 2000.
17.
KatoH., KuwanoH., NakajimaM., MiyazakiT., YoshikawaM., OjimaH., TsukadaK., OriuchiN., InoueT., EndoK.: Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.Cancer, 94: 921–928, 2002.
18.
MakuuchiH., TanakaH., ShimadaH., ChinoO., NishiT., MachimuraT., NakasakiH., MitomiT.: Esoophageal cancer and multiple primary cancer.Gan To Kagaku Ryoho, 24: 1–7, 1997.
19.
ShinodaM., TakagiI., KunishimaK.: Multiple primary malignancies combined with esophagus and other organs.J Jpn Surg Assoc, 51: 2371–2376, 1990.
20.
MoriS., MatsubaraT., YamadaK., NakagawaA., HosoiN., YamaguchiT.: A curatively treated case of primary cancers of five different organs including the esophagus.J Jpn Surg Assoc, 64: 2058–2061, 2003.
